Functional Improvement at One Year in Fibrotic Interstitial Lung Diseases—Prognostic Value of Baseline Biomarkers and Anti-Inflammatory Therapies

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Diagnostics

Topics

Medicine

Cancer Oncology

Pathology

Physiology

Internal Medicine

Show all topics

DOI

10.3390/diagnostics14141544

License

CC-BY

Other Formats

PDF